CD8

Alzheimer’s disease Amyloidosis Aβ response B cells CD8(+) T cells

Journal

Brain, behavior, and immunity
ISSN: 1090-2139
Titre abrégé: Brain Behav Immun
Pays: Netherlands
ID NLM: 8800478

Informations de publication

Date de publication:
25 Aug 2024
Historique:
received: 01 05 2024
revised: 01 08 2024
accepted: 22 08 2024
medline: 28 8 2024
pubmed: 28 8 2024
entrez: 27 8 2024
Statut: aheadofprint

Résumé

Alzheimer's disease (AD) is linked to toxic Aβ plaques in the brain and activation of innate responses. Recent findings however suggest that the disease may also depend on the adaptive immunity, as B cells exacerbate and CD8

Identifiants

DOI: 10.1016/j.bbi.2024.08.045 PMID: 39191349
pubmed: 39191349
pii: S0889-1591(24)00568-3
doi: 10.1016/j.bbi.2024.08.045
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Xin Wang (X)

Immunoregulation Section, Laboratory of Molecular Biology and Immunolgy, USA.

Britney Campbell (B)

Immunoregulation Section, Laboratory of Molecular Biology and Immunolgy, USA.

Monica Bodogai (M)

Immunoregulation Section, Laboratory of Molecular Biology and Immunolgy, USA.

Ross A McDevitt (RA)

Mouse Phenotyping Unit, Comparative Medicine Section, National Institute on Aging, Baltimore, MD, USA.

Anton Patrikeev (A)

Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA, USA.

Fedor Gusev (F)

Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA, USA.

Emeline Ragonnaud (E)

Immunoregulation Section, Laboratory of Molecular Biology and Immunolgy, USA.

Konda Kumaraswami (K)

Immunoregulation Section, Laboratory of Molecular Biology and Immunolgy, USA.

Sophie Shirenova (S)

The Leslie and Susan Gonda Multidisciplinary Brain Research Center, Israel; The Mina and Everard Goodman Faculty of Life Sciences, Israel; The Paul Feder Laboratory on Alzheimer's Disease Research, Bar-Ilan University, Ramat Gan, Israel.

Karin Vardy (K)

The Leslie and Susan Gonda Multidisciplinary Brain Research Center, Israel; The Mina and Everard Goodman Faculty of Life Sciences, Israel; The Paul Feder Laboratory on Alzheimer's Disease Research, Bar-Ilan University, Ramat Gan, Israel.

Mohamed-Gabriel Alameh (MG)

Institute of RNA Innovation, University of Pennsylvania, Philadelphia, PA, USA.

Drew Weissman (D)

Institute of RNA Innovation, University of Pennsylvania, Philadelphia, PA, USA.

Hellen Ishikawa-Ankerhold (H)

Department of Medicine I, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany; Institute of Surgical Research at the Walter Brendel Centre of Experimental Medicine, University Hospital, LMU Munich, Munich, Germany.

Eitan Okun (E)

The Leslie and Susan Gonda Multidisciplinary Brain Research Center, Israel; The Mina and Everard Goodman Faculty of Life Sciences, Israel; The Paul Feder Laboratory on Alzheimer's Disease Research, Bar-Ilan University, Ramat Gan, Israel.

Evgeny Rogaev (E)

Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA, USA.

Arya Biragyn (A)

Immunoregulation Section, Laboratory of Molecular Biology and Immunolgy, USA. Electronic address: biragyna@mail.nih.gov.

Classifications MeSH